| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forma Therapeutics Holdings, Inc. | SVP, Chief Medical Officer | Common Stock | 104,884 | $529,664 | $5.05 | 08 Apr 2022 | Direct |
| Forma Therapeutics Holdings, Inc. | SVP, Chief Medical Officer | Stock Option (Right to Buy) | 55,134 | 13 Apr 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322014827-kelly-patrick-f-2022-04-13 | Forma Therapeutics Holdings, Inc. | 13 Apr 2022 | 2 | +$75,750 | 4 | SVP, Chief Medical Officer | 14 Apr 2022, 18:10 |
| /report/000089924322008639-kelly-patrick-f-2022-02-28 | Forma Therapeutics Holdings, Inc. | 28 Feb 2022 | 2 | $0 | 4 | SVP, Chief Medical Officer | 02 Mar 2022, 16:12 |
| /report/000089924322007921-kelly-patrick-f-2022-02-23 | Forma Therapeutics Holdings, Inc. | 23 Feb 2022 | 1 | -$51,283 | 4 | SVP, Chief Medical Officer | 25 Feb 2022, 16:08 |